Keywords: morphosys, provides, update, current, status, coming, development

MorphoSys provides update on current status and coming development in 2009

Article | 26 January 2009

Munich, Germany-based synthetic antibody specialist MorphoSys has updated investors on its planned developments for 2009, particularly in its partnered antibody pipeline.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Drug Discovery

Go to company listing